[go: up one dir, main page]

NO20002012D0 - Nye polymorfe former av cipamfylline - Google Patents

Nye polymorfe former av cipamfylline

Info

Publication number
NO20002012D0
NO20002012D0 NO20002012A NO20002012A NO20002012D0 NO 20002012 D0 NO20002012 D0 NO 20002012D0 NO 20002012 A NO20002012 A NO 20002012A NO 20002012 A NO20002012 A NO 20002012A NO 20002012 D0 NO20002012 D0 NO 20002012D0
Authority
NO
Norway
Prior art keywords
cipamylline
polymorphic forms
new polymorphic
new
forms
Prior art date
Application number
NO20002012A
Other languages
English (en)
Other versions
NO20002012L (no
Inventor
Drake Eggleston
Ian Robert Lynch
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Publication of NO20002012L publication Critical patent/NO20002012L/no
Publication of NO20002012D0 publication Critical patent/NO20002012D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO20002012A 1997-10-23 2000-04-17 Nye polymorfe former av cipamfylline NO20002012D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6323897P 1997-10-23 1997-10-23
PCT/US1998/022451 WO1999020625A1 (en) 1997-10-23 1998-10-23 Novel polymorphic forms of cipamfylline

Publications (2)

Publication Number Publication Date
NO20002012L NO20002012L (no) 2000-04-17
NO20002012D0 true NO20002012D0 (no) 2000-04-17

Family

ID=22047900

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002012A NO20002012D0 (no) 1997-10-23 2000-04-17 Nye polymorfe former av cipamfylline

Country Status (28)

Country Link
US (2) US6583283B1 (no)
EP (1) EP1025103A4 (no)
JP (1) JP2001520228A (no)
KR (1) KR20010031246A (no)
CN (1) CN1280579A (no)
AP (1) AP2000001793A0 (no)
AR (1) AR015190A1 (no)
AU (1) AU751561B2 (no)
BG (1) BG104368A (no)
BR (1) BR9814099A (no)
CA (1) CA2306980A1 (no)
CO (1) CO4990930A1 (no)
DZ (1) DZ2629A1 (no)
EA (1) EA003445B1 (no)
HU (1) HUP0100019A3 (no)
ID (1) ID23885A (no)
IL (1) IL135711A0 (no)
MA (1) MA24682A1 (no)
NO (1) NO20002012D0 (no)
NZ (1) NZ504051A (no)
PE (1) PE122599A1 (no)
PL (1) PL340257A1 (no)
SA (1) SA99191117A (no)
SK (1) SK5642000A3 (no)
TR (1) TR200001109T2 (no)
UY (2) UY25220A1 (no)
WO (1) WO1999020625A1 (no)
ZA (1) ZA989622B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436551A1 (en) 2001-01-31 2002-08-08 Pfizer Products Inc. Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
NZ526531A (en) 2001-01-31 2005-02-25 Pfizer Prod Inc Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
EE200300360A (et) 2001-01-31 2003-12-15 Pfizer Products Inc. PDE4 isosüümide inhibiitoritena kasutatavad nikotiinamiidi biarüülderivaadid
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
PE20040538A1 (es) 2002-05-31 2004-08-30 Schering Corp Polimorfos inhibidores de xantina fosfodiesterasa v
CA2565965A1 (en) 2004-05-06 2006-07-27 Plexxikon, Inc. Pde4b inhibitors and uses therefor
CA2583428A1 (en) 2004-09-03 2006-03-09 Plexxikon, Inc. Bicyclic heteroaryl pde4b inhibitors
DE602006012871D1 (de) * 2005-09-20 2010-04-22 Scinopharm Singapore Pte Ltd Neue kristallformen von irinotecan-hydrochlorid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8906792D0 (en) 1989-03-23 1989-05-10 Beecham Wuelfing Gmbh & Co Kg Treatment and compounds
GB9020959D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds
GB9020921D0 (en) * 1990-09-26 1990-11-07 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
NZ504051A (en) 2003-02-28
SK5642000A3 (en) 2000-09-12
EP1025103A4 (en) 2001-11-14
AR015190A1 (es) 2001-04-18
MA24682A1 (fr) 1999-07-01
CN1280579A (zh) 2001-01-17
SA99191117A (ar) 2005-12-03
JP2001520228A (ja) 2001-10-30
WO1999020625A1 (en) 1999-04-29
PE122599A1 (es) 2000-02-12
TR200001109T2 (tr) 2000-09-21
CA2306980A1 (en) 1999-04-29
BG104368A (en) 2001-02-28
AU751561B2 (en) 2002-08-22
KR20010031246A (ko) 2001-04-16
NO20002012L (no) 2000-04-17
ZA989622B (en) 1999-04-23
HUP0100019A3 (en) 2003-01-28
US20020173648A1 (en) 2002-11-21
BR9814099A (pt) 2000-10-10
US6583283B1 (en) 2003-06-24
CO4990930A1 (es) 2000-12-26
HUP0100019A2 (hu) 2002-01-28
ID23885A (id) 2000-05-25
IL135711A0 (en) 2001-05-20
PL340257A1 (en) 2001-01-29
DZ2629A1 (fr) 2003-03-08
UY25380A1 (es) 1999-11-17
AP2000001793A0 (en) 2000-06-30
EP1025103A1 (en) 2000-08-09
AU1274499A (en) 1999-05-10
UY25220A1 (es) 2001-08-27
EA003445B1 (ru) 2003-06-26
EA200000448A1 (ru) 2000-10-30

Similar Documents

Publication Publication Date Title
FI973596A0 (fi) Identifikation av talaktiviteten av en kaella
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
NO20000226L (no) Nye spiroazabicykliske heterocykliske forbindelser
NO20000312D0 (no) Nye forbindelser
NO983356L (no) Nye 19-nor-pregnenderivater
NO20002787D0 (no) Nye forbindelser
NO20001938D0 (no) Nye aryloksy-alkyl-dialkylaminer
NO20011083L (no) Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH
NO970521D0 (no) Aktivering av brönnverktöy
ID24458A (id) Modifikasi rheologi in-sito poliolefin
BR9709098A (pt) Produção de semente apomítica
NO20002012D0 (no) Nye polymorfe former av cipamfylline
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
NO990832D0 (no) Syntese av bisendolylmalimider
FI971909A0 (fi) Bearbetning av taetningsytan pao doerrposten foer en koksningsugn
NO20010553D0 (no) Krystallinske former av osanetant
ID22379A (id) Hidrogenasi imina enamina
DE69811256D1 (de) Polymorphe modifikationen von dofetilid
NO20012276L (no) Identifisering av SENV-genotyper
BR9708718A (pt) Sínteses de aminas substituídas
ID23019A (id) Metode pembuatan turunan nitroguadinin
FI980215A0 (fi) Foerfarande och anordning foer placering av omslagsplattor pao massabalar
NO992110D0 (no) Syntese av benzo[f]kinoliner
NO995430D0 (no) Nye heterosykliske forbindelser
BR9704770A (pt) Derivados de 1-carba-(detia)-cefalosporina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application